FDA Inspection 838148 — Samuel N. Lederman, M.D.

Samuel N. Lederman, M.D. — FEI 3010160490

The FDA completed an inspection of Samuel N. Lederman, M.D. on June 3, 2013 in Palm Springs, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 3, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Palm Springs, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent